First-pass and steady-state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium

Journal of Magnetic Resonance Imaging

Volumn 30, Issue 4, 2009, Pages 809-816

  Naehle, Claas P ^a   Müller, Andreas ^a   Willinek, Winfried A ^a   Meyer, Carsten ^a   Hestermann, Tobias ^a   Gieseke, Juergen ^b   Schild, Hans ^a   Thomas, Daniel ^a  

^a UNIVERSITY OF BONN   (Germany)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

Gadofosveset trisodium; Heart; MRI angiography; Thorax

Indexed keywords

GADOFOSVESET;

ADULT; AGED; AORTA ARCH; ARTICLE; BLOOD VESSEL DIAMETER; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY SINUS; ELECTROCARDIOGRAM; FEMALE; HUMAN; IMAGE QUALITY; LUNG BLOOD VESSEL; LUNG DISEASE; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY VEIN; STEADY STATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; CORONARY CIRCULATION; FEMALE; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; RETROSPECTIVE STUDIES; THORAX;

EID: 70349671451     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21919     Document Type: Article

References (28)

1. Didier D, Ratib O, Beghetti M, Oberhaensli I, Friedli B. Morphologic and functional evaluation of congenital heart disease by magnetic resonance imaging. J Magn Reson Imaging 1999;10:639-655. (Pubitemid 29519765)
2. Borisch I, Horn M, Butz B, et al. Preoperative evaluation of carotid artery stenosis: comparison of contrast-enhanced MR angiography and duplex sonography with digital subtraction angiography. AJNR Am J Neuroradiol 2003;24:1117-1122. (Pubitemid 36734232)
3. Chung T. Assessment of cardiovascular anatomy in patients with congenital heart disease by magnetic resonance imaging. Pediatr Cardiol 2000;21:18-26. (Pubitemid 30068812)
4. De Cobelli F, Venturini M, Vanzulli A, et al. Renal arterial stenosis: prospective comparison of color Doppler US and breath-hold, three-dimensional, dynamic, gadolinium-enhanced MR angiography. Radiology 2000;214:373-380. (Pubitemid 30077691)
5. Greil GF, Powell AJ, Gildein HP, Geva T. Gadolinium-enhanced three-dimensional magnetic resonance angiography of pulmonary and systemic venous anomalies. J Am Coll Cardiol 2002;39:335-341. (Pubitemid 34084642)
6. Rofsky NM, Adelman MA. MR angiography in the evaluation of atherosclerotic peripheral vascular disease. Radiology 2000;214:325-338. (Pubitemid 30077685)
7. Stuber M, Botnar RM, Danias PG, et al. Contrast agent-enhanced, free-breathing, three-dimensional coronary magnetic resonance angiography. J Magn Reson Imaging 1999;10:790-799. (Pubitemid 29519783)
8. Randoux B, Marro B, Koskas F, Chiras J, Dormont D, Marsault C. Proximal great vessels of aortic arch: comparison of three-dimensional gadolinium-enhanced MR angiography and digital subtraction angiography. Radiology 2003;229:697-702. (Pubitemid 37467571)
9. Fenchel M, Saleh R, Dinh H, et al. Juvenile and adult congenital heart disease: time-resolved 3D contrast-enhanced MR angiography. Radiology 2007;244:399-410. (Pubitemid 47080871)
10. Korperich H, Gieseke J, Esdorn H, et al. Ultrafast time-resolved contrast-enhanced 3D pulmonary venous cardiovascular magnetic resonance angiography using SENSE combined with CENTRA-keyhole. J Cardiovasc Magn Reson 2007;9:77-87. (Pubitemid 46018485)
11. Finn JP, Baskaran V, Carr JC, et al. Thorax: low-dose contrast-enhanced three-dimensional MR angiography with subsecond temporal resolution - initial results. Radiology 2002;224:896-904. (Pubitemid 34919829)
12. Shamsi K, Yucel EK, Chamberlin P. A summary of safety of gadofosveset (MS-325) at 0.03 mmol/kg body weight dose: Phase II and Phase III clinical trials data. Invest Radiol 2006;41:822-830. (Pubitemid 44566363)
13. Steger-Hartmann T, Graham PB, Muller S, Schweinfurth H. Preclinical safety assessment of Vasovist (gadofosveset trisodium), a new magnetic resonance imaging contrast agent for angiography. Invest Radiol 2006;41:449-459. (Pubitemid 44284193)
14. Hartmann M, Wiethoff AJ, Hentrich HR, Rohrer M. Initial imaging recommendations for Vasovist angiography. Eur Radiol 2006;16(Suppl 2):B15-23.
15. Klessen C, Hein PA, Huppertz A, et al. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine. Investig Radiol 2007;42:659-664. (Pubitemid 47262935)
16. Nikolaou K, Kramer H, Grosse C, et al. High-spatial-resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience. Radiology 2006;241:861-872. (Pubitemid 46190554)
17. Kelle S, Thouet T, Tangcharoen T, et al. Whole-heart coronary magnetic resonance angiography with MS-325 (Gadofosveset). Med Sci Monit 2007;13:CR469-474. (Pubitemid 350106392)
18. Bluemke DA, Stillman AE, Bis KG, et al. Carotid MR angiography: phase II study of safety and efficacy for MS-325. Radiology 2001;219:114-122.
19. Hadizadeh DR, Gieseke J, Lohmaier SH, et al. Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR angiography and DSA. Radiology 2008;249:701-711.
20. Peters DC, Wylie JV, Hauser TH, et al. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology 2007;243:690-695.
21. Hendrick RE, Raff U. Image contrast and noise. In: Stark D, Bradley W, editors. Magnetic resonance imaging. St. Louis: Mosby Year Book; 1992. p 109-144.
22. Groves EM, Bireley W, Dill K, Carroll TJ, Carr JC. Quantitative analysis of ECG-gated high-resolution contrast-enhanced MR angiography of the thoracic aorta. AJR Am J Roentgenol 2007;188:522-528. (Pubitemid 46167756)
23. Godart F, Labrot G, Devos P, McFadden E, Rey C, Beregi JP. Coarctation of the aorta: comparison of aortic dimensions between conventional MR imaging, 3D MR angiography, and conventional angiography. Eur Radiol 2002;12:2034-2039. (Pubitemid 36940292)
24. Siegelman ES, Charafeddine R, Stolpen AH, Axel L. Suppression of intravascular signal on fat-saturated contrast-enhanced thoracic MR arteriograms. Radiology 2000;217:115-118. (Pubitemid 33097586)
25. Amano Y, Takahama K, Kumita S. Non-contrast-enhanced MR angiography of the thoracic aorta using cardiac and navigator-gated magnetization-prepared three-dimensional steady-state free precession. J Magn Reson Imaging 2008;27:504-509. (Pubitemid 351354733)
26. Francois CJ, Tuite D, Deshpande V, Jerecic R, Weale P, Carr JC. Unenhanced MR angiography of the thoracic aorta: initial clinical evaluation. AJR Am J Roentgenol 2008;190:902-906. (Pubitemid 351571486)
27. Hackenbroch M, Nehrke K, Gieseke J, et al. 3D motion adapted gating (3D MAG): a new navigator technique for accelerated acquisition of free breathing navigator gated 3D coronary MR-angiography. Eur Radiol 2005;15:1598-1606. (Pubitemid 41102354)
28. Barrett CD, Di Biase L, Natale A. How to identify and treat patient with pulmonary vein stenosis post atrial fibrillation ablation. Curr Opin Cardiol 2009;24:42-49.